RT-30mg

Retatrutide

RT-3 is a synthetic peptide that acts on three distinct receptor sites: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. This novel molecular structure has made it a subject of significant interest in laboratory settings focused on metabolic research. In scientific studies, RT-3 is utilized to explore the synergistic effects of activating these three pathways simultaneously. Research indicates that this triple-agonist mechanism may influence biological processes related to energy expenditure, lipid metabolism, and glucose homeostasis more comprehensively than single or dual agonists.

For research and educational purposes. Not intended for human consumption. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.